Revalia Bio

Revalia Bio reimagines how we treat chronic diseases that end in organ failure. Revalia disrupts the current preclinical model for device and drug development by using human organs obtained from deceased donors. Their proprietary data capture, integration and analysis systems allows Revalia to record up to five days of

Revalia Bio is a company in biomedical engineering.

Profile

Revalia Bio reimagines how we treat chronic diseases that end in organ failure. Revalia disrupts the current preclinical model for device and drug development by using human organs obtained from deceased donors. Their proprietary data capture, integration and analysis systems allows Revalia to record up to five days of data (e.g., expression, metabolic, and functional) […]

Within the biomedical engineering space, the company focuses on its core offering rather than a broad product line.

Directory data places it at the Creative Destruction Lab alumni company stage.

Website: revaliabio.com/home